Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14604964rdf:typepubmed:Citationlld:pubmed
pubmed-article:14604964lifeskim:mentionsumls-concept:C0077678lld:lifeskim
pubmed-article:14604964lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:14604964lifeskim:mentionsumls-concept:C1155074lld:lifeskim
pubmed-article:14604964lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:14604964pubmed:issue5lld:pubmed
pubmed-article:14604964pubmed:dateCreated2004-2-20lld:pubmed
pubmed-article:14604964pubmed:abstractTextAggregation of the high-affinity immunoglobulin E (IgE) receptor (FcepsilonRI) on mast cells induces a number of biochemical events, including protein-tyrosine phosphorylation leading to degranulation and multiple cytokine gene transcription. Here, we have demonstrated that a second member of the Cbl family of ubiquitin-protein ligase Cbl-b translocates into the lipid raft after FcepsilonRI engagement. Overexpression of Cbl-b in the lipid raft inhibits FcepsilonRI-mediated degranulation and cytokine gene transcription through the distinct mechanism. A point mutation of Cys373 in the RING finger domain of Cbl-b abrogates the suppression of FcepsilonRI-mediated degranulation but not cytokine gene transcription. The antigen-induced tyrosine phosphorylation of FcepsilonRI, Syk, phospholipase C-gamma (PLC-gamma), activation of c-Jun N-terminal kinase (JNK), extracellular signal regulated kinase (ERK), inhibitor of nuclear factor kappaB kinase (IKK), and Ca++ influx were all suppressed in the cells overexpressing Cbl-b in the lipid raft. In particular, the expression amount of Gab2 protein and thereby its FcepsilonRI-mediated tyrosine phosphorylation were dramatically down-regulated by ubiquitin-protein ligase activity of Cbl-b. These results suggest that Cbl-b is a negative regulator of both Lyn-Syk-LAT and Gab2mediated complementary signaling pathways in FcepsilonRI-mediated mast cell activation.lld:pubmed
pubmed-article:14604964pubmed:languageenglld:pubmed
pubmed-article:14604964pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:citationSubsetAIMlld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14604964pubmed:statusMEDLINElld:pubmed
pubmed-article:14604964pubmed:monthMarlld:pubmed
pubmed-article:14604964pubmed:issn0006-4971lld:pubmed
pubmed-article:14604964pubmed:authorpubmed-author:YamamuraHiroh...lld:pubmed
pubmed-article:14604964pubmed:authorpubmed-author:SadaKiyonaoKlld:pubmed
pubmed-article:14604964pubmed:authorpubmed-author:MiahS M...lld:pubmed
pubmed-article:14604964pubmed:authorpubmed-author:MaenoKoichiro...lld:pubmed
pubmed-article:14604964pubmed:authorpubmed-author:KyoShinkouSlld:pubmed
pubmed-article:14604964pubmed:authorpubmed-author:QuXiujuanXlld:pubmed
pubmed-article:14604964pubmed:issnTypePrintlld:pubmed
pubmed-article:14604964pubmed:day1lld:pubmed
pubmed-article:14604964pubmed:volume103lld:pubmed
pubmed-article:14604964pubmed:ownerNLMlld:pubmed
pubmed-article:14604964pubmed:authorsCompleteYlld:pubmed
pubmed-article:14604964pubmed:pagination1779-86lld:pubmed
pubmed-article:14604964pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:meshHeadingpubmed-meshheading:14604964...lld:pubmed
pubmed-article:14604964pubmed:year2004lld:pubmed
pubmed-article:14604964pubmed:articleTitleNegative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.lld:pubmed
pubmed-article:14604964pubmed:affiliationDivision of Proteomics, Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe, Japan.lld:pubmed
pubmed-article:14604964pubmed:publicationTypeJournal Articlelld:pubmed
More...